No Detail Found!

Chinese medicine to regulate intestinal bacteria in the treatment of atherosclerosis: A review

Author(s)
Liu Ting-ting Heilongjiang University of Chinese Medicine,Harbin, Hei Longjiang Province,China
Liu Pi-hong The First Affiliated Hospital of Heilongjiang University of Chinese Medicine,Harbin,China
Peng Cai-liang The First Affiliated Hospital of Heilongjiang University of Chinese Medicine,Harbin,China
Geng Nai-zhi The First Affiliated Hospital of Heilongjiang University of Chinese Medicine,Harbin,China
Abstract
In recent years, several studies have shown that the stability of intestinal bacteria, which acts as a natural barrier, plays a key role fighting against cardiovascular disease. Dysbiosis of the gut microbiome can trigger inflammatory responses and oxidative stress damage, cause abnormal cholesterol metabolism and disrupt the levels of short-chain fatty acids, oxidized trimethylamine and bile acids, thus influencing the occurrence and development of atherosclerosis. Chinese medicine believes that the formation of atherosclerosis is related to the malfunction of the spleen in transportation and transformation, with the interplay of phlegm and blood stagnation being the primary pathogenesis. In addition, the gut micro biome is inextricably linked to the spleen. Ancient medical books recorded “the spleen is the source of phlegm production” and “the heart and small intestine are in close proximity to each other”, exploring its TCM pathogenesis from the perspective of phlegm and stasis. Therefore, this review explores the mechanisms by which intestinal micro biota affects atherosclerosis and summarizes the role of Chinese herbal medicine in modulating intestinal microbes in the treatment of AS, providing new ideas for the prevention and treatment of cardiovascular disease.
Publication Details
Page(s) 1599-1607
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 6, Year: 2024

Request the full text from PASTIC

Keywords
atherosclerosis, inflammation, Chinese medicine., Intestinal bacteria
References
Ai ZL,Zhang X,Ge W,Zhong YB,Wang HY,Zuo ZY,Liu DY .2022 .Salvia miltiorrhiza extract may exert an anti-obesity effect in rats with high-fat dietinduced obesity by modulating gut microbiome and lipid metabolism. World J. Gastroenterol., 28(43) : 6131-6156.
Bartolomaeus H,Balogh A,Yakoub M,Homann S,Markó L,Höges S,Tsvetkov D,Krannich A,Wundersitz S,Avery EG,Haase N,Kraker K,Hering L,Maase M,Kusche-Vihrog K,Grandoch M,Fielitz J,Kempa S,Gollasch M,Zhumadilov Z,Kozhakhmetov S,Kushugulova A,Eckardt KU,Dechend R,Rump LC,Forslund SK,Muller DN,Stegbauer J,Wilck N J .2019 .Short-chain fatty acid propionate protects from hypertensive cardiovascular damage. Circulation, 139(11) : 1407-1421.
Branchereau M,Burcelin R,Heymes C .2019 .The gut microbiome and heart failure: A better gut for a better heart. Rev. Endocr Metab Disord., 20(4) : 407-414.
Chan YK,Brar MS,Kirjavainen PV,Chen Y,Peng J,Li D,Leung FC,El-Nezami H .2016 .High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: A pilot study of high fat diet and its intervention with Lactobacillus rhamnosus GG (LGG) or telmisartan in ApoE(-/-) mice. , 16(1) : 264.
Chen ML,Yi L,Zhang Y,Zhou X,Ran L,Yang J,Zhu JD,Zhang QY,Mi MT .2016 .Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced Atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota. mBio., 7(2) : e02210-02215.
Chen R,Chen T,Zhou Z,Song Z,Feng W,Yang X,Wang X,Li B,Ding X,Zhang H,Wang Y .2022 .Integrated pyroptosis measurement and metabolomics to elucidate the effect and mechanism of tangzhiqing on atherosclerosis. Front Physiol, 13 : 937737.
Chen RQ,Xiong P,Zhou XX,Liang ZQ,Wu LZ .2008 .Effects of phlegm-dispelling and blood stasisresolving traditional Chinese drugs on the blood pressure and cell cycle of left ventricular cardiac myocytes in hypertensive rats. Nan Fang Yi Ke Da Xue Xue Bao., 28(10) : 1806-1809.
De Man AME,Amrein K,Casaer MP,Dizdar OS,van Zanten ARH,Gundogan K,Lepp L,Rezzi S,Shenkin A,Berger MM .2024 .LLL 44-4: Micronutrients in acute disease and critical illness. Clin Nutr ESPEN. , 61 : 437-446.
Dinu LD,Gatea F,Matei F,Banciu C,Vamanu E .2024 .Gut Microbiota Modulation by Selenium and Zinc Enrichment Postbiotic on Dysbiosis Associated with Hypertension. Curr. Vasc Pharmacol, 22(10) : 365-374.
El-Daly M,Pulakazhi Venu VK,Saifeddine M,Mihara K,Kang S,Fedak PWM,Alston LA,Hirota SA,Ding H,Triggle CR,Hollenberg MD .2018 .Hyperglycaemic impairment of PAR2-mediated vasodilation: Prevention by inhibition of aortic endothelial sodium-glucose-co-Transporter-2 and minimizing oxidative stress. Vascul Pharmacol, 109 : 56-71.
Fu T,Kim YC,Byun S,Kim DH,Seok S,Suino-Powell K,Xu HE,Kemper B,Kemper JK .2016 .FXR primes the Liver for intestinal FGF15 signaling by transient induction of β-Klotho. Mol. Endocrinol, 30(1) : 92-103.
Haghikia A,Zimmermann F,Schumann P,Jasina A,Roessler J,Schmidt D,Heinze P,Kaisler J,Nageswaran V,Aigner A,Ceglarek U,Cineus R,Hegazy AN,van der Vorst EPC,Doring Y,Strauch CM,Nemet I,Tremaroli V,Dwibedi C,Kränkel N,Leistner DM,Heimesaat MM,Bereswill S,Rauch G,Seeland U,Soehnlein O,Müller DN,Gold R,Backhed F,Hazen SL,Haghikia A,Landmesser U .2022 .Propionate attenuates atherosclerosis by immunedependent regulation of intestinal cholesterol metabolism. Eur Heart J., 43(6) : 518-533.
Inagaki T,Moschetta A,Lee YK,Peng L,Zhao G,Downes M,Yu RT,Shelton JM,Richardson JA,Repa JJ,Mangelsdorf DJ,Kliewer SA .2006 .Proc Natl Acad Sci U S A. , 103(10) : 3920-3925.
Jiang LP,Yu XH,Chen JZ,Hu M,Zhang YK,Lin HL,Tang WY,He PP,Ouyang XP PP .2022 .Histone Deacetylase 3: A potential therapeutic target for atherosclerosis. Aging Dis, 13(3) : 773-786.
Jitapunkul S,Chalaprawat M,Bunnag S,Bhuvapanich S,Kangkaya V,Pasatrat S,Vajanamarhutue C .1991 .The relationship between glucose and uric acid metabolism: Influence of short term allopurinol on glucose metabolism. J. Med, 74(2) : 80-86.
Jukema RA,Ahmed TAN,Tardif JC .2019 .Does low-density lipoprotein cholesterol induce inflammation? If so, does it matter? Current insights and future perspectives for novel therapies. BMC Med, 17(1) : 197.
Kim JY,Kim H,Jung BJ,Kim NR,Park JE,Chung DK .2013 .Lipoteichoic acid isolated from Lactobacillus plantarum suppresses LPS-mediated atherosclerotic plaque inflammation. Mol. Cells, 35(2) : 115-124.
Kim SG,Sung JY,Kang YJ,Choi HC .2023 .Fisetin alleviates cellular senescence through PTEN mediated inhibition of PKCδ-NOX1 pathway in vascular smooth muscle cells. Arch Gerontol Geriatr., 108 : 104927.
Li N,Salter RC,Ramji DP .2011 .Molecular mechanisms underlying the inhibition of IFN-γ- induced, STAT1-mediated gene transcription in human macrophages by simvastatin and agonists of PPARs and LXRs. J. Cell Biochem, 112(2) : 675-683.
Lin Y,Zhu W,Chen X .2020 .The involving progress of MSCs based therapy in atherosclerosis. Stem Cell Res Ther., 11(1) : 216.
Liu FY,Wen J,Hou J,Zhang SQ,Sun CB,Zhou LC,Yin W,Pang WL,Wang C,Ying Y,Han SS,Yan JY,Li CX,Yuan JL,Xing HJ,Yang ZS .2021 .Gastrodia remodels intestinal microflora to suppress inflammation in mice with early atherosclerosis. Int. Immunopharmacol., 96 : 107758.
Lotti S,Dinu M,Colombini B,Amedei A,Sofi F A .2023 .Circadian rhythms, gut microbiota and diet: Possible implications for health. Nutr Metab Cardiovasc Dis. , 33(8) : 1490-1500.
Luo T,Liu D,Guo Z,Chen P,Guo Z,Ou C,Chen M C .2022 .Deficiency of proline/serine-rich coiled-coil protein 1 (PSRC1) accelerates trimethylamine N-oxideinduced atherosclerosis in ApoE(-/-) mice. J Mol Cell Cardiol, 170 : 60-74.
Lv S,Wang Y,Zhang W,Shang H W .2022 .Trimethylamine oxide: A potential target for heart failure therapy. Heart., 108(12) : 917-922.
Ma G,Pan B,Chen Y,Guo C,Zhao M,Zheng L,Chen B .2017 .Trimethylamine N-oxide in atherogenesis: Impairing endothelial self-repair capacity and enhancing monocyte adhesion. Biosci. Rep, 37(2) : 244.
Ma H,Patti ME H .2014 .Bile acids, obesity, and the metabolic syndrome. Best Pract. Res. Clin. Gastroenterol, 28(4) : 573-583.
Ma L,Guo X,Chen W .2015 .Inhibitory effects of oleoylethanolamide (OEA) on H2O2-induced human umbilical vein endothelial cell (HUVEC) injury and apolipoprotein E knockout (ApoE-/-) atherosclerotic mice. Int. J. Clin. Exp. Pathol., 8(6) : 6301-6311.
Ma ZM,Ouyang H,Ni J,Lyu Z,Li H Z .2024 .Traditional Chinese medicine preparations in medical institutions: current situation and inspirations on research and development of new traditional Chinese medicine preparations. Zhongguo Zhong Yao Za Zhi., 49(5) : 1415-1420.
Nijmeijer RM,Schaap FG,Smits AJ,Kremer AE,Akkermans LM,Kroese AB,Rijkers GT,Schipper ME,Verheem A,Wijmenga C,Gooszen HG .2014 .Impact of global Fxr deficiency on experimental acute pancreatitis and genetic variation in the FXR locus in human acute pancreatitis. PLoS One, 9(12) : e114393.
O'Morain VL,Chan YH,Williams JO,Alotibi R,Alahmadi A,Rodrigues NP,Plummer SF,Hughes TR,Michael DR,Ramji DP .2021 .The Lab4P consortium of probiotics attenuates atherosclerosis in LDL receptor deficient mice fed a high fat diet and causes plaque stabilization by inhibiting inflammation and several pro-atherogenic processes. Mol. Nutr, 65(17) : e2100214.
Pang J,Hu P,Wang J,Jiang J,Lai J .2019 .Vorapaxar stabilizes permeability of the endothelial barrier under cholesterol stimulation via the AKT/JNK and NF- κB signaling pathways. Mol. Med, 19(6) : 5291-5300.
Pęczek P,Leśniewski M,Mazurek T,Szarpak L,Filipiak KJ,Gąsecka A .2021 .Antiplatelet effects of PCSK9 inhibitors in primary hypercholesterolemia. Life (Basel), 11(6) : 466.
Peng S,Xu LW,Che XY,Xiao QQ,Pu J,Shao Q,He B .2018 .Atorvastatin inhibits inflammatory response, attenuates lipid deposition and improves the stability of vulnerable atherosclerotic plaques by modulating autophagy. Front Pharmacol, 9 : 438.
Pols TW,Nomura M,Harach T,Lo Sasso G,Oosterveer MH,Thomas C,Rizzo G,Gioiello A,Adorini L,Pellicciari R,Auwerx J,Schoonjans K J .2011 .TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab, 14(6) : 747-757.
Qi Y,Liu W,Yan X,Zhang C,Zhang C,Liu L,Zheng X,Suo M,Ti Y,Ni M,Zhang M,Bu P .2022 .Tongxinluo may alleviate inflammation and improve the stability of atherosclerotic plaques by changing the intestinal flora. Front Pharmacol, 13 : 805266.
Rani D,Kaur S,Dey JK,Dey SK .2024 .Engineering immune response to regulate cardiovascular disease and cancer. Adv. Protein Chem Struct. Biol, 140 : 381-417.
Reich M,Spomer L,Klindt C,Fuchs K,Stindt J,Deutschmann K,Hohne J,Liaskou E,Hov JR,Karlsen TH,Beuers U,Verheij J,Ferreira-Gonzalez S,Hirschfield G,Forbes SJ,Schramm C,Esposito I,Nierhoff D,Fickert P,Fuchs CD,Trauner M,GarcíaBeccaria M,Gabernet G,Nahnsen S,Mallm JP,Vogel M,Schoonjans K,Lautwein T,Köhrer K,Häussinger D,Luedde T,Heikenwalder M,Keitel V .2021 .Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis. J Hepatol, 75(3) : 634-646.
Shabalala SC,Dludla PV,Mabasa L,Kappo AP,Basson AK,Pheiffer C,Johnson R C .2020 .The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling. Biomed Pharmacother, 131 : 110785.
Sheng Y,Meng G,Zhou Z,Du R,Wang Y,Jiang M Y .2023 .PARP-1 inhibitor alleviates liver lipid accumulation of atherosclerosis via modulating bile acid metabolism and gut microbes. Mol. Omics, 19(7) : 560-573.
Singh HK,Biswas AK,Philip J,Kushwaha N,Mukherjee B,Baranwal AK B .2022 .A study to assess the relationship between donor uric acid levels and supernatant hemolysis in stored packed red blood cell units. Asian J. Transfus Sci., 16(2) : 251-256.
Song L,Zhang J,Lai R,Li Q,Ju J,Xu H J .2021 .Chinese herbal medicines and active metabolites: Potential antioxidant treatments for atherosclerosis. Front Pharmacol, 12 : 675999.
Su YS,Ali MS,Pukenas BA,Favilla CG,Zanaty M,Hasan DM,Kung DK DM .2020 .Novel treatment of cerebral vasospasm using solitaire stent retrieverassisted angioplasty: Case series. , 135 : e657-e663.
Swanepoel I,Roberts A,Brauns C,Chaliha DR,Papa V,Palmer RD,Vaccarezza M .2022 .Trimethylamine N-oxide (TMAO): A new attractive target to decrease cardiovascular risk. Postgrad Med, 98(1163) : 723-727.
Tan YL,Ou HX,Zhang M,Gong D,Zhao ZW,Chen LY,Xia XD,Mo ZC,Tang CK .2019 .Tanshinone IIA promotes macrophage cholesterol efflux and attenuates atherosclerosis of apoE-/- mice by omentin-1/ABCA1 Pathway. Curr. Pharm. Biotechnol, 20(5) : 422-432.
Tu R and Xia J .2024 .Stroke and vascular cognitive impairment: The role of intestinal microbiota metabolite TMAO. CNS Neurol Disord Drug Targets, 23(1) : 102-121.
Verhaar BJH,Prodan A,Nieuwdorp M,Muller M M .2020 .Gut microbiota in hypertension and atherosclerosis: A review. Nutrients, 12(10) : 2982.
Wang F,Tang Wang Z,J Wang Z .2023 .The interactions of Candida albicans with gut bacteria: A new strategy to prevent and treat invasive intestinal candidiasis. Gut Pathog, 15(1) : 30.
Wang X,Luo D,Wu S D .2021 .Molecular dysfunctions of mitochondria-associated endoplasmic reticulum contacts in atherosclerosis. Oxid. Med, : 2424509.
Wang Y,Qin C,Tian S,Meng Y,Chen Y,Fu S,Xu M,Wang B,Li Y,Ouyang Q,Ling H,Liu M H .2024 .Dataset on cardiac structural and functional parameters in TMAO-challenged mouse. Data Brief, 54 : 110465.
Wang Z,Klipfell E,Bennett BJ,Koeth R,Levison BS,Dugar B,Feldstein AE,Britt EB,Fu X,Chung YM,Wu Y,Schauer P,Smith JD,Allayee H,Tang WH,DiDonato JA,Lusis AJ,Hazen SL .2011 .Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, 472(7341) : 57-63.
Wu M,Yang S,Wang S,Cao Y,Zhao R,Li X,Xing Y,Liu L Y,- Y .2020 .Effect of berberine on atherosclerosis and gut microbiota modulation and their correlation in high-fat diet-fed ApoE. , 11 : 223.
Xie L,Chi X,Wang H,Dai A,Dong J,Liu S,Zhang D .2023 .Mechanism of action of buckwheat quercetin in regulating lipid metabolism and intestinal flora via Toll-like receptor 4 or nuclear factor κB pathway in rats on a high-fat diet. , 115 : 112148.
Xu L,Li X,Zhang Y,Ding M,Sun B,Su G,Zhao Y .2021 .The effects of linalool acupoint application therapy on sleep regulation. RSC Adv, 11(11) : 5896-5902.
Yang P,Li Z,Li H,Lu Y,Wu H,Li Z H .2015 .Pyruvate kinase M2 accelerates pro-inflammatory cytokine secretion and cell proliferation induced by lipopolysaccharide in colorectal cancer. Cell Signal, 27(7) : 1525-1532.
Yin H,Liu N,Chen J .2022 .The role of the intestine in the development of hyperuricemia. , 13 : 845684.
Yoo JY,Groer M,Dutra SVO,Sarkar A,Mc Skimming DI .2046 .Gut microbiota and immune system interactions. Microorganisms., 8(10) : .
Yoo JY,Sniffen S,McGill Percy KC,Pallaval VB,Chidipi B .2022 .Gut dysbiosis and immune system in atherosclerotic cardiovascular disease (ACVD). Microorganisms, 10(1) : 108.
Zhang Y,Liu Y,Li Y,Zhao X,Zhuo L,Zhou A,Zhang L,Su Z,Chen C,Du S,Liu D,Ding X .2019 .Hierarchical and complex system entropy clustering analysis based validation for traditional chinese medicine syndrome patterns of chronic atrophic gastritis. J. Altern. Complement. Med, 25(11) : 1130-1139.
Zhao D,Liu J,Wang M,Zhang X,Zhou M .2019 .Epidemiology of cardiovascular disease in China: Current features and implications. Nat. Rev. Cardiol., 16(4) : 203-212.
Zhao H,Lu Z,Lu Y .2022 .The potential of probiotics in the amelioration of hyperuricemia. , 13(5) : 2394-2414.
Zhao J,Li Y,Xin L,Sun M,Yu C,Shi G,Bao T,Liu J,Ni Y,Lu R,Wu Y,Fang Z Y .2020 .Clinical features and rules of chinese herbal medicine in diabetic peripheral neuropathy patients. Evid. Based Complement. Alternat. Med, : 5795264.
Zhong H,Wang L,Jia F,Yan Y,Xiong F,Li Y,Hidayat K,Guan R K .2024 .Effects of Lactobacillus plantarum supplementation on glucose and lipid metabolism in type 2 diabetes mellitus and prediabetes: A systematic review and meta-analysis of randomized controlled trials. Clin. Nutr, 61 : 377-384.
0

Citations

0

Downloads

90

Views